Again interesting reading, mostly what we already know, but on page 2 the following sentence from Mr Rogers, I haven't read before.
He said that should Prima be able to replicate the results from the 2006 phaseIIa trial, THE AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION WOULD ALLOW THE CVAC TO BE PRESCRIBED TO PATIENTS IN AUSTRALIS "OFF-LICENCE THROUGH ANZGOG"
I knew we where lookin at CVAC possibly being released in Australia and other areas before US with all going to plan, I wasn't aware that it simply(nothing is simple) needs to replicate previous results!
http://www.biotechdaily.com.au/media/backissues/2009%20March/BD%20Biotech%20Daily%20March%2011.pdf
interesting, page-11
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.8¢ | $684.8K | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 436502 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 92443 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |